A team of scientists from Imperial College London and the University of Hong Kong have made a breakthrough in the visualisation of human brain tissue structure at a microscopic level.
Parkinson's UK in Scotland has told the Scottish Parliament that the Brexit process is causing concern for people with Parkinson's around their ability to access essential medication.
Parkinson's UK is partnering with US biotech Neurolixis to accelerate the development of a promising new drug that could prevent one of the most debilitating side effects of Parkinson's medication – dyskinesia.
Research exploring whether the elimination of senescent cells could hold therapeutic promise for halting the progression of sporadic Parkinson's has been published.
Parkinson's UK is delighted to announce that Annie Macleod has taken up her role as the new Director of Parkinson's UK in Scotland.